ARIAD Appoints CEO
This article was originally published in Scrip
ARIAD Pharmaceuticals, Inc. has appointed Paris Panayiotopoulos president, CEO and to its board of directors – effective Jan. 1, 2016. Panayiotopoulos most recently was president of EMD Serono, Inc. and will succeed ARIAD's founder, chair and CEO Harvey J. Berger. Previously, Panayiotopoulos was at Eli Lilly & Co.